Insider · CIK 0001577014

Rhodes Jason P

Reports to the SEC for 5 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001577014

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-14	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−1.36M sh	$25.00	−$34M	2,441,454
2026-08-14	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−478K sh	$25.00	−$12M	567,358
2026-08-14	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−322K sh	$25.00	−$8.06M	428,946
2026-08-13	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−268K sh	$26.20	−$7.03M	3,801,128
2026-08-13	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−94.4K sh	$26.20	−$2.47M	1,045,735
2026-08-13	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−63.6K sh	$26.20	−$1.67M	751,411
2026-07-07	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−124K sh	$23.17	−$2.88M	4,099,069
2026-07-07	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−29.6K sh	$23.62	−$699K	4,069,482
2026-07-07	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−62.5K sh	$23.17	−$1.45M	1,154,994
2026-07-07	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−14.8K sh	$23.62	−$351K	1,140,150
2026-07-07	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−49.2K sh	$23.17	−$1.14M	826,719
2026-07-07	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−11.7K sh	$23.62	−$276K	815,054
2026-07-07	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−5,000 sh	$23.61	−$118K	2,962
2026-07-06	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−253K sh	$22.79	−$5.77M	4,223,448
2026-07-06	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−127K sh	$22.79	−$2.9M	1,217,537
2026-07-06	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−100K sh	$22.79	−$2.28M	875,912
2026-06-29	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−103K sh	$21.14	−$2.18M	4,476,487
2026-06-29	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−51.8K sh	$21.14	−$1.09M	1,344,719
2026-06-29	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−40.7K sh	$21.14	−$860K	975,931
2026-06-26	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−163K sh	$21.28	−$3.47M	4,579,456
2026-06-26	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−81.9K sh	$21.28	−$1.74M	1,396,475
2026-06-26	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−64.4K sh	$21.28	−$1.37M	1,016,633
2026-06-25	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−12.7K sh	$21.10	−$268K	4,742,410
2026-06-25	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−6,382 sh	$21.10	−$135K	1,478,378
2026-06-25	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−5,019 sh	$21.10	−$106K	1,081,044
2026-06-24	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−50.5K sh	$21.02	−$1.06M	4,755,109
2026-06-24	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−25.4K sh	$21.02	−$534K	1,484,760
2026-06-24	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−20K sh	$21.02	−$420K	1,086,063
2026-06-23	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−77.9K sh	$21.13	−$1.65M	4,805,639
2026-06-23	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−39.1K sh	$21.13	−$827K	1,510,157
2026-06-23	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−30.8K sh	$21.13	−$650K	1,106,036
2026-06-05	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+35.2K sh	—	—	35,152
2026-05-06	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−21.9K sh	$18.18	−$399K	1,549,288
2026-05-06	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−43.6K sh	$18.18	−$793K	4,883,494
2026-05-06	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−428 sh	$18.18	−$7,781.04	7,962
2026-05-06	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−17.2K sh	$18.18	−$313K	1,136,810
2026-05-05	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−3,056 sh	$18.03	−$55.1K	1,571,214
2026-05-05	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−6,081 sh	$18.03	−$110K	4,927,115
2026-05-05	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−60 sh	$18.03	−$1,081.8	8,390
2026-05-05	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−2,403 sh	$18.03	−$43.3K	1,154,054
2026-05-04	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−3,136 sh	$18.00	−$56.4K	1,574,270
2026-05-04	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−6,241 sh	$18.00	−$112K	4,933,196
2026-05-04	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−61 sh	$18.00	−$1,098	8,450
2026-05-04	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−2,466 sh	$18.00	−$44.4K	1,156,457
2026-04-28	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−59.9K sh	$18.38	−$1.1M	1,577,432
2026-04-28	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−119K sh	$18.38	−$2.19M	4,939,489
2026-04-28	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−1,170 sh	$18.38	−$21.5K	8,512
2026-04-28	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−47.1K sh	$18.38	−$865K	1,158,944
2026-04-28	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−26 sh	$19.00	−$494	1,577,406
2026-04-28	DYNDyne Therapeutics, Inc.S Sale	Director	SSale	−52 sh	$19.00	−$988	4,939,437

Recent filings

Accepted (ET)
Aug 174
Rhodes Jason P0001577014-26-000016
SEC(opens sec.gov)
Jul 84
Rhodes Jason P0001577014-26-000014
SEC(opens sec.gov)
Jun 304
Rhodes Jason P0001577014-26-000012
SEC(opens sec.gov)

Companies

Address

C/O DYNE THERAPEUTICS, INC. 1560 TRAPELO ROAD

WALTHAM, MA, 02451